Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To understand if Mexiletine will restores normal colonic motility in a patient with irritable
bowel syndrome - constipation (IBS-C) and a genetic mutation in SCN5A.